Corpus Intelligence IC Memo — RH OF NORTHWESTARKANSAS LLC 2026-04-26 06:36 UTC
IC Memo — RH OF NORTHWESTARKANSAS LLC
Investment Committee Memorandum | AR | 25 beds | Grade D | EBITDA uplift $761K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

RH OF NORTHWESTARKANSAS LLC

CCN 042009 | WASHINGTON, AR | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

RH OF NORTHWESTARKANSAS LLC is a 25-bed community hospital in WASHINGTON, AR with $10.3M in net patient revenue and a 1.4% operating margin. The hospital serves a payer mix of 45.0% Medicare, 0.0% Medicaid, and 55.0% commercial.

Thesis: Turnaround. Our ML models identify $761K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.4% to 8.8% (+742bps).

Net Revenue HCRIS$10.3M
Current EBITDA COMPUTED$143K
Operating Margin COMPUTED1.4%
Occupancy HCRIS59.8%
Revenue / Bed COMPUTED$410K
Net-to-Gross HCRIS10.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
52
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 1.4% places it above the state median. Among 52 size-comparable peers (12-50 beds), the median margin is -15.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 52 hospitals in the comp set.

HospitalStateBedsRevenueMargin
RH OF NORTHWESTARKANSAS LLC (Target)AR25$10.3M1.4%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
DREW MEMORIAL HOSPITAL INCAR49$35.3M-27.2%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%
OZARK HEALTH INCAR25$32.3M-4.7%
FORREST CITY MEDICAL CENTERAR48$30.3M-17.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $761K (742bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$215K+210bp18mo
Denial Rate Reduction12.0%6.5%$206K+201bp12mo
Cost to Collect4.5%2.5%$205K+200bp12mo
A/R Days Reduction5200.0%3800.0%$125K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+9bp6mo

5. EBITDA Bridge

Net Collection Rate
$215K
Denial Rate Reduction
$206K
Cost to Collect
$205K
A/R Days Reduction
$125K
Clean Claim Rate
$10K
Total EBITDA Uplift$761K
Current EBITDA$143K
+ RCM Uplift+$761K
Pro Forma EBITDA$904K
Current Margin1.4%
Pro Forma Margin8.8%
WC Released (1x)$393K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$221K$8.6M38.75x107.8%
Base (11x exit)10.0x11.0x$221K$9.5M42.95x112.1%
Bull Case9.0x11.0x$199K$12.1M60.73x127.3%
Bull (12x exit)9.0x12.0x$199K$13.2M66.54x131.5%
Bear Case11.0x10.0x$243K$4.7M19.27x80.7%
Bear (11x exit)11.0x11.0x$243K$5.2M21.52x84.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 52 hospitals with 12-50 beds
  • Same-state prioritization (n=53)
  • Comp margins: P25=-24.5% / P50=-15.1% / P75=-2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.